Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

The authors reply.

Morris AM, Bai A, Burry L, Dresser LD, McIntyre M, Nelson S, So M, Bell C.

Crit Care Med. 2019 Aug;47(8):e719-e720. doi: 10.1097/CCM.0000000000003858. No abstract available.

PMID:
31305310
2.

Long-Term Effects of Phased Implementation of Antimicrobial Stewardship in Academic ICUs: 2007-2015.

Morris AM, Bai A, Burry L, Dresser LD, Ferguson ND, Lapinsky SE, Lazar NM, McIntyre M, Matelski J, Minnema B, Mok K, Nelson S, Poutanen SM, Singh JM, So M, Steinberg M, Bell CM.

Crit Care Med. 2019 Feb;47(2):159-166. doi: 10.1097/CCM.0000000000003514.

PMID:
30407951
3.

Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings.

Morris AM, Rennert-May E, Dalton B, Daneman N, Dresser L, Fanella S, Grant J, Keynan Y, Le Saux N, McDonald J, Shevchuk Y, Thirion D, Conly JM.

Antimicrob Resist Infect Control. 2018 Aug 29;7:104. doi: 10.1186/s13756-018-0396-z. eCollection 2018. Review.

4.

Funding for Antimicrobial Stewardship Programs: A Customizable Business Case Template.

Le Saux N, Dalton B, Abbass K, Conly J, Daneman N, Dresser L, Fanella S, German G, Grant J, Keynan Y, Lau TTY, McDonald J, Nott C, Patrick D, Shevchuk Y, Thirion D, Morris A.

Can J Hosp Pharm. 2018 Jan-Feb;71(1):50-51. Epub 2018 Mar 7. No abstract available.

5.

Residual Kidney Function and Peritoneal Dialysis-Associated Peritonitis Treatment Outcomes.

Whitty R, Bargman JM, Kiss A, Dresser L, Lui P.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2016-2022. doi: 10.2215/CJN.00630117. Epub 2017 Nov 7.

6.

Use of a structured panel process to define antimicrobial prescribing appropriateness in critical care.

Dresser LD, Bell CM, Steinberg M, Ferguson ND, Lapinsky S, Lazar N, Murphy P, Singh JM, Morris AM.

J Antimicrob Chemother. 2018 Jan 1;73(1):246-249. doi: 10.1093/jac/dkx341.

PMID:
29029170
7.

Chest CT scans are frequently abnormal in asymptomatic patients with newly diagnosed acute myeloid leukemia.

Vallipuram J, Dhalla S, Bell CM, Dresser L, Han H, Husain S, Minden MD, Paul NS, So M, Steinberg M, Vallipuram M, Wong G, Morris AM.

Leuk Lymphoma. 2017 Apr;58(4):834-841. doi: 10.1080/10428194.2016.1213825. Epub 2016 Sep 19.

PMID:
27642861
8.

Developing and expanding hospital antimicrobial stewardship: The Ontario experience.

Nakamachi Y, West S, Dresser L, Morris AM.

Can Commun Dis Rep. 2015 Jun 18;41(Suppl 4):14-18. doi: 10.14745/ccdr.v41is4a04. eCollection 2015 Jun 18.

9.

Pathway to Prevention of Nosocomial Clostridium difficile Infection.

Goldstein EJ, Johnson S, Maziade PJ, McFarland LV, Trick W, Dresser L, Millette M, Mazloum H, Low DE.

Clin Infect Dis. 2015 May 15;60 Suppl 2:S148-58. doi: 10.1093/cid/civ142.

PMID:
25922401
10.

A National Survey of Critical Care Physicians' Knowledge, Attitudes, and Perceptions of Antimicrobial Stewardship Programs.

Steinberg M, Dresser LD, Daneman N, Smith OM, Matte A, Marinoff N, Bell CM, Morris AM.

J Intensive Care Med. 2016 Jan;31(1):61-5. doi: 10.1177/0885066614541922. Epub 2014 Jul 8.

PMID:
25005699
11.

Optimized dosing of cefazolin in patients treated with nocturnal home hemodialysis.

Law V, Walker S, Dresser L, Cardone KE, Richardson R, Chan C, Battistella M.

Am J Kidney Dis. 2014 Sep;64(3):479-80. doi: 10.1053/j.ajkd.2014.05.007. Epub 2014 Jun 11. No abstract available.

PMID:
24927899
12.

An update on vancomycin dosing and monitoring practices in hemodialysis patients.

Zhang M, Dresser L, Battistella M.

CANNT J. 2013 Oct-Dec;23(4):25-7; quiz 28-9. No abstract available.

PMID:
24660521
13.

Outpatient parenteral antimicrobial therapy for surgery patients: A comparison with previous standard of care.

Yang A, Fung R, Brunton J, Dresser L.

Can J Infect Dis Med Microbiol. 2013 Summer;24(2):74-8.

14.

Use of a structured panel process to define quality metrics for antimicrobial stewardship programs.

Morris AM, Brener S, Dresser L, Daneman N, Dellit TH, Avdic E, Bell CM.

Infect Control Hosp Epidemiol. 2012 May;33(5):500-6. doi: 10.1086/665324. Epub 2012 Mar 20.

PMID:
22476277
15.

Impact of accessory gene regulator (agr) dysfunction on vancomycin pharmacodynamics among Canadian community and health-care associated methicillin-resistant Staphylococcus aureus.

Tsuji BT, MacLean RD, Dresser LD, McGavin MJ, Simor AE.

Ann Clin Microbiol Antimicrob. 2011 May 20;10:20. doi: 10.1186/1476-0711-10-20.

16.

Practice spotlight: pharmacists in an antimicrobial stewardship program.

Dresser L, Nelson S.

Can J Hosp Pharm. 2010 Jul;63(4):328-9. No abstract available.

17.

An assessment of linezolid utilization in selected canadian provinces.

Walker S, Dresser L, Becker D, Scalera A.

Can J Infect Dis Med Microbiol. 2006 May;17(3):177-82.

18.

Antipneumococcal activity of ertapenem compared with gatifloxacin in a temperature-sensitive murine model of acute pneumonia.

De Azavedo JC, Dresser L, Duncan CL, Walker SE, Low DE, Bast DJ.

J Chemother. 2007 Aug;19(4):392-7.

PMID:
17855183
19.

Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.

Muller MP, Dresser L, Raboud J, McGeer A, Rea E, Richardson SE, Mazzulli T, Loeb M, Louie M; Canadian SARS Research Network.

Pharmacotherapy. 2007 Apr;27(4):494-503.

PMID:
17381375
20.

Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in mice.

Bast DJ, Dresser L, Duncan CL, Walker SE, Mandell LA, Low DE, de Azavedo JC.

J Chemother. 2006 Dec;18(6):634-40.

PMID:
17267342
21.

Early diagnosis of SARS: lessons from the Toronto SARS outbreak.

Muller MP, Richardson SE, McGeer A, Dresser L, Raboud J, Mazzulli T, Loeb M, Louie M; Canadian SARS Research Network.

Eur J Clin Microbiol Infect Dis. 2006 Apr;25(4):230-7.

PMID:
16586072
22.

Outpatient gatifloxacin therapy and dysglycemia in older adults.

Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C, Dresser L, Low DE, Mamdani MM.

N Engl J Med. 2006 Mar 30;354(13):1352-61. Epub 2006 Mar 1.

23.

Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin.

Bast DJ, Yue M, Chen X, Bell D, Dresser L, Saskin R, Mandell LA, Low DE, de Azavedo JC.

Antimicrob Agents Chemother. 2004 Sep;48(9):3343-8.

24.

Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.

Knowles SR, Phillips EJ, Dresser L, Matukas L.

Clin Infect Dis. 2003 Oct 15;37(8):1139-42. Epub 2003 Sep 12.

PMID:
14523782
25.
26.

Stroke: no more diagnose and adios.

Dresser LP.

Del Med J. 1999 Feb;71(2):81-3. No abstract available.

PMID:
10079594
28.

The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.

Dresser LD, Rybak MJ.

Pharmacotherapy. 1998 May-Jun;18(3):456-62. Review.

PMID:
9620097
29.

Ipecac myopathy and cardiomyopathy.

Dresser LP, Massey EW, Johnson EE, Bossen E.

J Neurol Neurosurg Psychiatry. 1993 May;56(5):560-2.

30.

A case of myelinoclastic diffuse sclerosis in an adult.

Dresser LP, Tourian AY, Anthony DC.

Neurology. 1991 Feb;41(2 ( Pt 1)):316-8.

PMID:
1992384
31.

Anatomic and pathophysiologic studies of the human internal jugular valve.

Dresser LP, McKinney WM.

Am J Surg. 1987 Aug;154(2):220-4.

PMID:
3631396

Supplemental Content

Loading ...
Support Center